Skip to main content

Transplantation Disease Transmission clinical trials at UCSF
1 research study open to eligible people

  • Prevention of De Novo HCV With Antiviral HCV Therapy Post-Liver and Post-Kidney Transplant

    open to all eligible people

    In this study, subjects that do not have Hepatitis C virus (HCV) will be transplanted with livers or kidneys from donors who do have HCV. Medications that are used to treat HCV will be given to the study subjects shortly after transplant to protect them from developing the problems HCV can cause to the liver.

    San Francisco, California and other locations

Last updated: